NSE/BSE Codes: NSE: MAXHEALTH, BSE: 543220
Summary of Key Information:
Nature of Event / Disclosure:
Regulatory disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding status update of proceedings before National Company Law Tribunal, Cuttack Bench.
Involved Parties / Authorities:
- Legal representatives of BRS Capital Two Pte. Limited (Petitioner)
- Kalinga Hospital Ltd (Subsidiary of Max Healthcare Institute Limited)
- Other shareholder of KHL from whom Max Healthcare acquired majority equity stake
- Max Healthcare Institute Limited
- Hon'ble National Company Law Tribunal, Cuttack Bench
Date / Timeline of Event:
- Previous intimations: May 19, 2026 and July 8, 2026
- Current hearing date: July 23, 2026 at 2:30 pm IST
- Next hearing date: August 4, 2026
Brief Description of Outcome / Dispute:
The Hon'ble National Company Law Tribunal, Cuttack Bench has adjourned the matter to August 4, 2026 for further hearing. The petitions were filed by legal representatives of BRS Capital Two Pte. Limited against Kalinga Hospital Ltd (subsidiary), the other shareholder of KHL, and Max Healthcare Institute Limited.
Impact of Outcome:
Financial Impact:
No material financial impact disclosed in this update. No settlement, compensation, or penalty amounts have been determined or paid as of this adjournment.
Operational / Business / Strategic Impact:
No specific operational, business, or strategic impacts disclosed in this status update. The matter remains pending before NCLT.
Other Implications:
No reputational, legal, regulatory, or market perception effects explicitly stated in this procedural update.
Next Steps / Required Actions:
The matter has been adjourned to August 4, 2026 for further hearing. The company is required to continue complying with SEBI LODR disclosure requirements as the proceedings develop.